Brief report: Multisystem Langerhans-cell histiocytosis with life-threatening pulmonary involvement - Good response to cyclosporine A

Medical and Pediatric Oncology

Volumn 35, Issue 4, 2000, Pages 438-442

  Zeller, B ^a,c   Storm Mathisen, I ^b   Smevik, B ^b   Lie, S O ^b  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c Sentralsykehuset i Akershus   (Norway)

Author keywords

Cyclosporine A; Langerhans cell histiocytosis; Lung cysts; Mechanical ventilation; Recurrent pneumothoraces

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; CYCLOSPORIN A; ETOPOSIDE; INTERLEUKIN 2; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; PURINE DERIVATIVE; THYMOCYTE ANTIBODY; THYMUS HORMONE; VINBLASTINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CHILD CARE; CLINICAL FEATURE; DISEASE COURSE; HEPATOSPLENOMEGALY; HISTIOCYTOSIS X; HISTOPATHOLOGY; HUMAN; LANGERHANS CELL; LUNG CYST; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MAINTENANCE THERAPY; MORTALITY; ONSET AGE; PNEUMOTHORAX; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; REMISSION; SALVAGE THERAPY; SIDE EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME; DIFFERENTIAL DIAGNOSIS; FEMALE; INFANT; LUNG TUMOR; RADIOGRAPHY;

CYCLOSPORINE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LUNG NEOPLASMS; PNEUMOTHORAX;

EID: 0033805768     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-911X(20001001)35:4<438::AID-MPO12>3.0.CO;2-4     Document Type: Article

References (14)

1. Treatment of Langerhans cell histiocytosis - Evolution and current approaches
2. Langerhans cells histiocytosis - Still an unsolved problem
3. Current therapy of Langerhans cell histiocytosis
4. Multisystem Langerhans cell histiocytosis (LCH): Response to initial therapy heralds good prognosis
5. Cyclosporine therapy for advanced Langerhans cell histiocytosis
6. Cyclosporine therapy for refractory Langerhans cell histiocytosis
7. Cyclosporine therapy for refractory Langerhans cell histiocytosis
8. Treatment of relapsed Langerhans cell histiocytosis by cyclosporin A combined with etoposid and prednisone
9. Cyclosporine therapy for Langerhans cell histiocytosis
10. Cyclosporine A therapy for multisystem Langerhans cell histiocytosis
11. Cyclosporine therapy in recurrent Langerhans cell histiocytosis. Preliminary results from the AIEOP ICL-R93 study
12. Results of the Histiocyte Society Cyclosporine Salvage therapy questionnaire
13. Lung involvement in Langerhans cell histiocytosis: Prevalence, clinical features, and outcome
14. Pulmonary and mediastinal lesions in children with Langerhans cell histiocytosis